171 related articles for article (PubMed ID: 38359971)
1. Epigenetic control of cell signalling in cancer stem cells.
Joshi G; Basu A
Int Rev Cell Mol Biol; 2024; 383():67-88. PubMed ID: 38359971
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract][Full Text] [Related]
3. Role of epigenetic modulation in cancer stem cell fate.
Deshmukh A; Binju M; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2017 Sep; 90():9-16. PubMed ID: 28711634
[TBL] [Abstract][Full Text] [Related]
4. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
5. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.
Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY
Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295
[TBL] [Abstract][Full Text] [Related]
6. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
[TBL] [Abstract][Full Text] [Related]
7. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
[TBL] [Abstract][Full Text] [Related]
8. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway.
Akhtar S; Hourani S; Therachiyil L; Al-Dhfyan A; Agouni A; Zeidan A; Uddin S; Korashy HM
Semin Cancer Biol; 2022 Aug; 83():177-196. PubMed ID: 32877761
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the Hedgehog and Wnt pathways in cancer.
Wils LJ; Bijlsma MF
Crit Rev Oncol Hematol; 2018 Jan; 121():23-44. PubMed ID: 29279097
[TBL] [Abstract][Full Text] [Related]
11. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
Das PK; Islam F; Lam AK
Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
[TBL] [Abstract][Full Text] [Related]
12. Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells.
Li X; Wang X; Xie C; Zhu J; Meng Y; Chen Y; Li Y; Jiang Y; Yang X; Wang S; Chen J; Zhang Q; Geng S; Wu J; Zhong C; Zhao Y
Anticancer Drugs; 2018 Mar; 29(3):208-215. PubMed ID: 29356693
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics.
Tandon I; Waghmode A; Sharma NK
Curr Cancer Drug Targets; 2019; 19(11):877-884. PubMed ID: 31393247
[TBL] [Abstract][Full Text] [Related]
15. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
Marquardt JU; Factor VM; Thorgeirsson SS
J Hepatol; 2010 Sep; 53(3):568-77. PubMed ID: 20646772
[TBL] [Abstract][Full Text] [Related]
17. Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells.
Samadani AA; Norollahi SE; Rashidy-Pour A; Mansour-Ghanaei F; Nemati S; Joukar F; Afshar AM; Ghazanfari S; Safizadeh M; Rostami P; Gatei M
Biomed Pharmacother; 2018 Dec; 108():590-599. PubMed ID: 30243093
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells.
Yu Z; Pestell TG; Lisanti MP; Pestell RG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
[TBL] [Abstract][Full Text] [Related]
19. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
Bhal S; Kundu CN
Med Oncol; 2023 Jan; 40(2):82. PubMed ID: 36662310
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell epigenetics and chemoresistance.
Crea F; Danesi R; Farrar WL
Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]